Zhihong Liu

ORCID: 0000-0001-6093-0726 · 8 papers in corpus
lab-animal 2026
International journal of cancer ·doi:10.1002/ijc.70341

Ovarian clear cell carcinoma (CCC) is an aggressive subtype of ovarian cancer that is resistant to conventional chemotherapy, resulting in poor prognosis. CCC develops from endometriosis, which exposes tumor cells to a hypoxic microenvironm…

lab-animal 2023
Materials today. Bio ·doi:10.1016/j.mtbio.2023.100855

Severe endometrial injury caused by invasive uterine operation and/or endometritis often results in intrauterine adhesions (IUAs), which are named Asherman's syndrome (AS), further leading to menstrual disorders, infertility and severe comp…

other 2021
Frontiers in cellular and infection microbiology ·doi:10.3389/fcimb.2021.788836

The diagnosis of endometriosis is typically delayed by years for the unexclusive symptom and the traumatic diagnostic method. Several studies have demonstrated that gut microbiota and cervical mucus potentially can be used as auxiliary diag…

2020
·doi:10.1166/nnl.2020.3184

Endometriosis (EM) is a condition characterized by the growth of functional endometrium in areas other than the uterus. In this study, microRNAs (miRNAs) were extracted from peripheral blood platelets from patients diagnosed with EM and fro…

lab-animal 2019
Experimental and therapeutic medicine ·doi:10.3892/etm.2019.7522

Endometriosis is a common gynecological disease with manifestations of endometrial-like tissue outside the uterus. Transforming growth factor-β (TGF-β) is known to facilitate a series of biological events in many cells, including migration.…

other 2019
Human Reproduction ·doi:10.1093/humrep/dez252

STUDY QUESTION: What is the expression level of T-cadherin in endometriosis, and does T-cadherin play a role in regulating invasion and migration of endometrial stromal cells? SUMMARY ANSWER: T-cadherin expression was reduced in ectopic en…

rct 2017
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.13420

AIM: To compare the therapeutic effect of 1.88-mg and 3.75-mg gonadotrophin-releasing hormone agonist (GnRHa) in the treatment of stage III-IV endometriosis after laparoscopic surgery. METHODS: Fifty patients with stage III-IV endometriosi…

observational 2013
Journal of ovarian research ·doi:10.1186/1757-2215-6-47

OBJECTIVE: The true incidence of ovarian tumors in children is unknown. Few studies beyond case reports and case series have been published concerning pediatric ovarian tumors. Herein we review a large number of ovarian tumor cases. METHOD…